cysteine has been researched along with Amyotrophic Lateral Sclerosis in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.79) | 18.7374 |
1990's | 5 (8.93) | 18.2507 |
2000's | 23 (41.07) | 29.6817 |
2010's | 20 (35.71) | 24.3611 |
2020's | 7 (12.50) | 2.80 |
Authors | Studies |
---|---|
Kouznetsova, VL; Teigen, K; Tsigelny, IF; Zhang, A | 1 |
Kuroi, K; Nakabayashi, T; Ohyama, T; Tahara, S; Yamazaki, K | 1 |
Ahn, J; Baek, Y; Ha, NC; Kwon, Y; Lee, D; Park, BJ; Woo, TG | 1 |
Barros, TP; Dobson, CM; Esbjörner, EK; Hanspal, MA; Kumita, JR; Matharu, NS; Ng, JSW; Wilson, MR; Yerbury, JJ | 1 |
Atkin, JD; Ma, Y; Mehta, P; Parakh, S; Perri, ER; Vidal, M; Walker, AK | 1 |
Bredvik, K; Calder, EL; Chen, Q; Cheng, RR; Fischer, SM; Gross, SS; Kawamata, H; Konrad, C; Manfredi, G; Roychoudhury, D; Sandhu, D; Schwartz, BI; Studer, L | 1 |
Cieplak, P; Deal, AK; Ghatak, S; Han, X; Lipton, SA; Martinez, FJ; Nakamura, T; Oh, CK; Pirie, E; Scott, HR; Yates, JR; Yeo, GW; Zhang, X | 1 |
Chen, J; Du, HN; He, ZX; Huang, BY; Li, C; Liang, JZ; Liang, Y; Liu, XL; Pang, DW; Tang, B; Wang, L; Xu, WC; Yang, Y; Yuan, HY; Zhang, M | 1 |
Antonyuk, SV; Banci, L; Barbieri, L; Capper, MJ; Hasnain, SS; Luchinat, E; McAlary, L; Mercatelli, E; O'Neill, PM; Wright, GSA; Yerbury, JJ | 1 |
Mitchell, SC; Rawlings, L; Steventon, GB; Turton, L | 1 |
Antinone, SE; Ghadge, GD; Green, WN; Lam, TT; Roos, RP; Wang, L | 1 |
Cai, T; Cai, W; Chen, L; Chen, Z; Cui, F; Huang, X; Mao, F; Sun, Z; Teng, H; Wang, J; Wang, Z; Yu, P | 1 |
Bisaglia, M; Bubacco, L; Cendron, L; Girotto, S; Mammi, S; Tessari, I; Zanotti, G | 1 |
English, AM; Martins, D | 1 |
Alegre-Cebollada, J; Álvarez-Zaldiernas, C; Badilla, CL; Blasi, J; Fernandez, JM; Kahn, TB; Solsona, C | 1 |
Araki, T; Fujiwara, N; Masutani, H; Nagano, S; Takahashi, Y; Urushitani, M; Yamamoto, K | 1 |
Furukawa, Y; Kurosawa, M; Nukina, N; Ogawa, M; Oka, K; Shidara, H | 1 |
Ishige, K; Ito, Y; Okawa, E; Ono, S; Suzuki, T; Tokuda, E; Watanabe, S | 1 |
Kawamata, H; Manfredi, G | 1 |
Woolsey, PB | 1 |
Beck, M; Drepper, C; Herrmann, T; Sendtner, M; Wessig, C | 1 |
Andersen, P; Birve, A; Brotherton, T; Glass, JD; Kelly, C; Marklund, SL; Polak, M | 1 |
Borchelt, DR; Brown, HH; Lelie, H; Prudencio, M; Valentine, JS; Whitelegge, JP | 1 |
Fujiwara, N; Ihara, K; Suzuki, K; Taniguchi, N; Torigoe, H; Wakatsuki, S; Yamaguchi, Y | 1 |
Akiyama, H; Aoki, M; Kato, M; Kato, S; Kobayashi, Z; Konno, H; Mizuno, H; Shimakura, N; Suzuki, N; Warita, H | 1 |
Chen, X; Cui, L; Guan, T; Kong, J; Li, C; Li, XM; Shang, H; Zhang, X | 1 |
Andersen, PM; Brännström, T; Graffmo, KS; Marklund, SL; Zetterström, P | 1 |
Borchelt, DR; Brown, HH; Patel, K; Roberts, BL | 1 |
Furukawa, Y; Toichi, K; Yamanaka, K | 1 |
Bruns, CK; Cardoso, RM; Craig, L; DiDonato, M; Getzoff, ED; Huff, ME; Kassmann, CJ; Kelly, JW; Lo, TP; Powers, ET; Tainer, JA; Thayer, MM | 1 |
Ding, F; Dokholyan, NV; Khare, SD | 1 |
Holmgren, A; Lindberg, MJ; Normark, J; Oliveberg, M | 1 |
Furukawa, Y; O'Halloran, TV | 1 |
Morahan, JM; Pamphlett, R; Trent, RJ; Yu, B | 1 |
Banci, L; Bertini, I; D'Amelio, N; Gaggelli, E; Libralesso, E; Matecko, I; Turano, P; Valentine, JS | 1 |
Banci, L; Bertini, I; Cantini, F; D'Amelio, N; Gaggelli, E | 1 |
Geffard, M; Lagroye, I; Salauze, L; van der Velden, C; Veyret, B | 1 |
Andersen, PM; Brännström, T; Eisen, A; Mackenzie, IR; Marklund, SL; Stewart, HG | 1 |
Borchelt, DR; Wang, J; Xu, G | 1 |
Deng, HX; Fu, R; Furukawa, Y; O'Halloran, TV; Siddique, T | 1 |
Dziedzic, T; Figlewicz, DA; Malecki, MT; Partyka, D; Pera, J; Slowik, A; Szczudlik, A; Tomik, B; Turaj, W; Wolkow, PP | 1 |
Carrì, MT; Casciati, A; Cozzolino, M; Crosio, C; Ferri, A; Gralla, EB; Nencini, M; Rotilio, G; Valentine, JS | 1 |
Beal, MF; Brown, RH; Bush, AI; Culotta, VC; Duce, J; Hayward, LJ; Kiaei, M; Li, QX; Nagano, S; Sakoda, S; Tiwari, A; Tucker, SM; Watanabe, S; Yoshihara, S | 1 |
Bacci, A; Carlesi, C; Coppedè, F; Lo Gerfo, A; Mancuso, M; Micheli, D; Migliore, L; Murri, L; Nesti, C; Petrozzi, L; Piazza, S; Rocchi, A; Siciliano, G | 1 |
Doyu, M; Ishigaki, S; Katsuno, M; Niwa, J; Sobue, G; Sone, J; Takahashi, M; Tanaka, F; Yamada, S | 1 |
Eguchi, H; Fujiwara, N; Kato, S; Nakano, M; Ookawara, T; Suzuki, K; Taniguchi, N; Yoshihara, D | 1 |
Banci, L; Bertini, I; Boca, M; Girotto, S; Martinelli, M; Valentine, JS; Vieru, M | 1 |
Borchelt, DR; Karch, CM | 1 |
Akiguchi, I; Kato, T; Sugiyama, H | 1 |
Foster, H; Pean, A; Steventon, GB; Sturman, S; Waring, RH; Williams, AC | 1 |
Borchelt, DR; Brown, RH; Cleveland, DW; Guarnieri, M; Lee, MK; Price, DL; Sisodia, SS; Slunt, HS; Wong, PC; Xu, ZS | 1 |
Tsunoda, M | 1 |
Beall, DP; Chin, BB; Martin, D | 1 |
Ai, J; Eggers, DK; Faull, KF; Goto, JJ; Gralla, EB; Liu, H; Nersissian, AM; Sanders-Loehr, J; Valentine, JS; Zhu, H | 1 |
Hansen, S; Krieger, C; Perry, TL; Tabatabaei, A | 1 |
1 review(s) available for cysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
1 trial(s) available for cysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
55 other study(ies) available for cysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Modeling of mutant superoxide dismutase 1 octamers with cross-linked disulfide bonds.
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; Humans; Mutation; Superoxide Dismutase; Superoxide Dismutase-1 | 2022 |
SOD1 gains pro-oxidant activity upon aberrant oligomerization: change in enzymatic activity by intramolecular disulfide bond cleavage.
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; Humans; Mutation; Reactive Oxygen Species; Superoxide Dismutase; Superoxide Dismutase-1 | 2022 |
Structural analysis of the overoxidized Cu/Zn-superoxide dismutase in ROS-induced ALS filament formation.
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; Humans; Mutation; Reactive Oxygen Species; Superoxide Dismutase; Superoxide Dismutase-1; Zinc | 2022 |
Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Cell Line, Tumor; Cell Nucleus; Cysteine; Cytosol; DNA-Binding Proteins; Electroporation; Fluoresceins; Fluorescent Dyes; Frontotemporal Lobar Degeneration; Humans; Kinetics; Models, Biological; Optical Imaging; Organometallic Compounds; Protein Transport; Sequence Tagged Sites; Time-Lapse Imaging; Transfection | 2019 |
The Cysteine (Cys) Residues Cys-6 and Cys-111 in Mutant Superoxide Dismutase 1 (SOD1) A4V Are Required for Induction of Endoplasmic Reticulum Stress in Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Cell Line, Tumor; Cysteine; Endoplasmic Reticulum Stress; Mice; Mutation, Missense; Neurons; Superoxide Dismutase-1 | 2020 |
Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients.
Topics: Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Cells, Cultured; Cysteine; Female; Fibroblasts; Glucose; Glutathione; Humans; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Middle Aged; Serine; Skin | 2020 |
S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.
Topics: Amyotrophic Lateral Sclerosis; Brain; Cysteine; DNA-Binding Proteins; Frontotemporal Dementia; Humans; Induced Pluripotent Stem Cells; Motor Neurons; Nitric Oxide; Protein Aggregation, Pathological; Reactive Nitrogen Species; RNA Processing, Post-Transcriptional; S-Nitrosothiols; Stress, Physiological | 2021 |
Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111.
Topics: Amyloid; Amyotrophic Lateral Sclerosis; Apoptosis; Cell Line, Tumor; Cysteine; DNA-Binding Proteins; Humans; Hydrogen Peroxide; Models, Biological; Protein Multimerization; Sulfenic Acids; Superoxide Dismutase-1 | 2018 |
The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation.
Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Asthma; Azoles; Crystallography, X-Ray; Cysteine; Disulfides; Edaravone; HEK293 Cells; Humans; Isoindoles; Molecular Chaperones; Mutation; Nuclear Magnetic Resonance, Biomolecular; Organoselenium Compounds; Protein Binding; Protein Folding; Protein Multimerization; Protein Stability; Superoxide Dismutase-1 | 2018 |
Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis.
Topics: Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Biotransformation; Cysteine; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Parkinson Disease; Phenotype; Phenylalanine Hydroxylase; Polymorphism, Genetic; Young Adult | 2019 |
Palmitoylation of superoxide dismutase 1 (SOD1) is increased for familial amyotrophic lateral sclerosis-linked SOD1 mutants.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cell Line, Tumor; Cell Membrane; Cysteine; Disulfides; HEK293 Cells; Humans; Lipoylation; Luminescent Proteins; Mass Spectrometry; Mice; Mice, Transgenic; Mutation; Neurons; Oxidation-Reduction; Protein Processing, Post-Translational; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2013 |
Identification of a novel missense (C7W) mutation of SOD1 in a large familial amyotrophic lateral sclerosis pedigree.
Topics: Adult; Aged; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; China; Cysteine; Female; Humans; Male; Middle Aged; Mutation, Missense; Pedigree; Superoxide Dismutase; Superoxide Dismutase-1; Tryptophan | 2014 |
DJ-1 is a copper chaperone acting on SOD1 activation.
Topics: Amyotrophic Lateral Sclerosis; Binding Sites; Copper; Crystallography, X-Ray; Cysteine; DNA, Complementary; Gene Expression Regulation, Enzymologic; Humans; Intracellular Signaling Peptides and Proteins; Models, Molecular; Molecular Chaperones; Oncogene Proteins; Oxidative Stress; Parkinson Disease; Peroxiredoxins; Protein Binding; Protein Conformation; Protein Deglycase DJ-1; Spectrometry, Fluorescence; Superoxide Dismutase; Superoxide Dismutase-1 | 2014 |
SOD1 oxidation and formation of soluble aggregates in yeast: relevance to sporadic ALS development.
Topics: Amyotrophic Lateral Sclerosis; Chromatography, High Pressure Liquid; Cysteine; Green Fluorescent Proteins; Histidine; Humans; Mutation; Oxidation-Reduction; Protein Folding; Protein Processing, Post-Translational; Protein Stability; Recombinant Fusion Proteins; Recombinant Proteins; Saccharomyces cerevisiae; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superoxide Dismutase; Superoxide Dismutase-1 | 2014 |
Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; Humans; Mutation, Missense; Oxidation-Reduction; Protein Structure, Secondary; Protein Unfolding; Superoxide Dismutase; Superoxide Dismutase-1 | 2014 |
A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cysteine; Disease Models, Animal; Gene Dosage; Humans; Mice; Mice, Transgenic; Motor Neurons; Mutation; Oxidation-Reduction; Phenotype; Physical Exertion; Protein Aggregation, Pathological; Protein Conformation; Protein Folding; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Transgenes | 2015 |
Cysteine residues in Cu,Zn-superoxide dismutase are essential to toxicity in Caenorhabditis elegans model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Caenorhabditis elegans; Cysteine; Disease Models, Animal; Superoxide Dismutase | 2015 |
Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Chelating Agents; Copper; Cysteine; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Humans; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molybdenum; Spinal Cord; Superoxide Dismutase; Survival Rate; Treatment Outcome | 2008 |
Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cysteine; Cytochrome Reductases; Frameshift Mutation; Gene Expression Regulation, Enzymologic; Humans; Mammals; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Models, Molecular; Molecular Chaperones; Molecular Sequence Data; Mutation; Protein Folding; Protein Structure, Tertiary; Protein Transport; Superoxide Dismutase; Superoxide Dismutase-1 | 2008 |
Cysteine, sulfite, and glutamate toxicity: a cause of ALS?
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Fatal Outcome; Female; Glutamates; Humans; Middle Aged; Sulfite Oxidase; Sulfites | 2008 |
C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany.
Topics: Aged; Amyotrophic Lateral Sclerosis; Arginine; Cysteine; DNA Mutational Analysis; Exons; Female; Germany; Humans; Male; Middle Aged; Mutation; Pedigree; RNA-Binding Protein FUS | 2011 |
A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; DNA Mutational Analysis; Female; Genetic Counseling; Genetic Testing; Genotype; Humans; Male; Mutation; Pedigree; Serine; Superoxide Dismutase; Superoxide Dismutase-1 | 2011 |
A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis-associated and experimental mutations in metal-binding residues and free cysteines lacks toxicity in vivo.
Topics: Amyotrophic Lateral Sclerosis; Animals; Binding Sites; Blotting, Northern; Cells, Cultured; Copper; Cysteine; HEK293 Cells; Histidine; Humans; Immunohistochemistry; Metals; Mice; Mice, Transgenic; Mutation; Polymerase Chain Reaction; RNA, Messenger; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Transfection; Zinc | 2012 |
Structural switching of Cu,Zn-superoxide dismutases at loop VI: insights from the crystal structure of 2-mercaptoethanol-modified enzyme.
Topics: Alkylation; Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Crystallography, X-Ray; Cysteine; Humans; Hydrogen Bonding; Mercaptoethanol; Models, Molecular; Oxidation-Reduction; Protein Conformation; Protein Multimerization; Protein Stability; Protein Structure, Secondary; Sequence Alignment; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Topics: Adult; Amyotrophic Lateral Sclerosis; Arginine; Brain; Cysteine; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; Female; Humans; Inclusion Bodies; Male; Mutation, Missense; Neuroglia; Neurons; RNA-Binding Protein FUS; Ubiquitin | 2012 |
S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Arginine; Biotin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Transgenic; Mutation; Neuroblastoma; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Disulfide-Isomerases; Protein Folding; S-Nitrosothiols; Spinal Cord; Subcellular Fractions; Superoxide Dismutase; Up-Regulation | 2013 |
Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Chelating Agents; Chromatography, Gel; Copper; Cysteine; Cystine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Hydrophobic and Hydrophilic Interactions; Longevity; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Oxidation-Reduction; Protein Conformation; Protein Folding; Recombinant Proteins; Solubility; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Zinc | 2013 |
Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures.
Topics: Amyotrophic Lateral Sclerosis; Animals; Bacterial Proteins; CHO Cells; Cricetinae; Cross-Linking Reagents; Cysteine; Disease Models, Animal; Disulfides; Humans; Inclusion Bodies; Luminescent Proteins; Mutation; Protein Folding; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Cross-Linking Reagents; Cysteine; Disulfides; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Kinetics; Mass Spectrometry; Models, Biological; Mutation; Protein Denaturation; Protein Folding; Sulfhydryl Compounds; Superoxide Dismutase; Temperature; Time Factors | 2013 |
ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization.
Topics: Amyotrophic Lateral Sclerosis; Binding Sites; Copper; Crystallography, X-Ray; Cysteine; Dimerization; Enzyme Stability; Humans; Hydrophobic and Hydrophilic Interactions; Macromolecular Substances; Microscopy, Atomic Force; Microscopy, Electron; Models, Molecular; Mutation; Protein Conformation; Superoxide Dismutase; Zinc | 2003 |
Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; Humans; Kinetics; Models, Molecular; Mutation; Protein Folding; Superoxide Dismutase; Thermodynamics | 2003 |
Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers.
Topics: Amyotrophic Lateral Sclerosis; Apoenzymes; Cysteine; Dimerization; Disulfides; Enzyme Stability; Humans; In Vitro Techniques; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Oxidation-Reduction; Protein Engineering; Protein Folding; Protein Structure, Quaternary; Recombinant Proteins; Superoxide Dismutase | 2004 |
Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.
Topics: Amyotrophic Lateral Sclerosis; Calorimetry, Differential Scanning; Chromatography, Gel; Cross-Linking Reagents; Cysteine; Disulfides; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Kinetics; Models, Biological; Mutation; Oxygen; Peptides; Protein Binding; Protein Denaturation; Protein Folding; Protein Processing, Post-Translational; Sulfhydryl Compounds; Superoxide Dismutase; Superoxide Dismutase-1; Temperature; Thermodynamics; Zinc | 2005 |
Screening the metallothionein III gene in sporadic amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Cysteine; Female; Gene Frequency; Genetic Testing; Genotype; Glycine; Humans; Male; Metallothionein 3; Middle Aged; Mutation; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2005 |
Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Binding Sites; Circular Dichroism; Copper; Crystallization; Crystallography, X-Ray; Cysteine; Disulfides; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Humans; Hydrogen Bonding; Ions; Magnetic Resonance Spectroscopy; Models, Molecular; Movement; Mutagenesis; Mutation; Polymerase Chain Reaction; Proteins; Spectrophotometry; Superoxide Dismutase; Zinc | 2005 |
Human SOD1 before harboring the catalytic metal: solution structure of copper-depleted, disulfide-reduced form.
Topics: Amyotrophic Lateral Sclerosis; Catalysis; Copper; Cysteine; Disulfides; Escherichia coli; Humans; Magnetic Resonance Spectroscopy; Models, Biological; Models, Molecular; Models, Statistical; Molecular Conformation; Mutation; Protein Conformation; Proteins; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Antibodies; Catecholamines; Cysteine; Female; Humans; Male; Middle Aged; Parkinson Disease | 2005 |
Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy.
Topics: Aged; Amyotrophic Lateral Sclerosis; Blotting, Western; Creatine; Cysteine; DNA Mutational Analysis; Family Health; Female; Glycine; Humans; Immunohistochemistry; Muscular Diseases; Mutation; Myosins; NAD; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Ubiquitin | 2006 |
Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation.
Topics: Age Factors; Amino Acid Motifs; Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cell Fractionation; Cysteine; Dimerization; Disease Models, Animal; Disulfides; Electrophoresis, Polyacrylamide Gel; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis; Protein Binding; Protein Folding; Spinal Cord; Superoxide Dismutase; Transfection | 2006 |
Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cross-Linking Reagents; Cysteine; Disulfides; Humans; Mice; Mice, Transgenic; Models, Molecular; Oxidation-Reduction; Oxidative Stress; Protein Conformation; Protein Folding; Spinal Cord; Superoxide Dismutase | 2006 |
Paraoxonase gene polymorphisms and sporadic ALS.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Arginine; Aryldialkylphosphatase; Chi-Square Distribution; Confidence Intervals; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Glutamine; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Poland; Polymorphism, Single Nucleotide; Retrospective Studies; Serine | 2006 |
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cysteine; Humans; Mice; Mitochondria; Motor Neurons; Mutation; Oxidation-Reduction; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Chlorocebus aethiops; Chromatography, Affinity; Copper; COS Cells; Cysteine; Enzyme Stability; Humans; Mice; Mice, Transgenic; Mutation; Serine; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Transfection | 2007 |
Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
Topics: Age Factors; Aged; Amino Acid Sequence; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cysteine; Disease Progression; DNA Glycosylases; DNA Mutational Analysis; Female; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Mutation; Phenotype; Polymorphism, Genetic; Serine; Sex Factors | 2007 |
Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1.
Topics: Amyotrophic Lateral Sclerosis; Animals; Carrier Proteins; Cell Line, Tumor; Cross-Linking Reagents; Cysteine; Disulfides; Mice; Mice, Transgenic; Models, Biological; Mutation; Oxidative Stress; Proteasome Endopeptidase Complex; Superoxide Dismutase; Superoxide Dismutase-1; Ubiquitin; Ubiquitin-Protein Ligases | 2007 |
Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cysteine; Humans; Hydrogen Peroxide; Lewy Bodies; Mass Spectrometry; Mercaptoethanol; Mice; Mutation; Oxidation-Reduction; Oxidative Stress; Recombinant Proteins; Superoxide Dismutase; Superoxide Dismutase-1 | 2007 |
SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization.
Topics: Amyotrophic Lateral Sclerosis; Cysteine; Dimerization; Humans; Hydrogen Bonding; Kinetics; Metals; Mitochondria; Mutation; Oxidation-Reduction; Protein Conformation; Superoxide Dismutase; Superoxide Dismutase-1 | 2008 |
A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Line; Cross-Linking Reagents; Cysteine; Disease Models, Animal; Disulfides; Humans; Mice; Mice, Transgenic; Models, Biological; Mutation; Protein Binding; Protein Folding; Superoxide Dismutase; Superoxide Dismutase-1 | 2008 |
[Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
Topics: 5-Hydroxytryptophan; Administration, Oral; Amyotrophic Lateral Sclerosis; Cysteine; Drug Evaluation; Humans; Injections, Intramuscular; Injections, Intravenous; Thyrotropin-Releasing Hormone | 1984 |
Pathways of cysteine metabolism in MND/ALS.
Topics: Adult; Amino Acids; Amyotrophic Lateral Sclerosis; Chromatography, High Pressure Liquid; Cysteamine; Cysteine; Cysteine Dioxygenase; Dioxygenases; Humans; Motor Neuron Disease; Oxygenases; Ranitidine | 1994 |
Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Arginine; Base Sequence; Cell Line; Cloning, Molecular; Consensus Sequence; Cysteine; DNA Primers; Genetic Carrier Screening; Genetic Linkage; Glycine; Humans; Isoenzymes; Kinetics; Lymphocytes; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Polymerase Chain Reaction; Recombinant Proteins; Superoxide Dismutase | 1994 |
[Changes in cysteine sulfinic acid in rat brain under the experimental elevation of taurine content].
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; Chromatography, High Pressure Liquid; Cysteine; Excitatory Amino Acids; Humans; Male; Neurotransmitter Agents; Nitrous Oxide; Rats; Rats, Wistar; Taurine; Thyroidectomy | 1996 |
Decreased bilateral frontal lobe perfusion in dementia of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Cysteine; Dementia; Female; Frontal Lobe; Humans; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 1998 |
Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant.
Topics: Amyotrophic Lateral Sclerosis; Arginine; Binding, Competitive; Cobalt; Copper; Cysteine; Histidine; Humans; Models, Molecular; Mutation; Protein Processing, Post-Translational; Saccharomyces cerevisiae; Silver; Spectrum Analysis, Raman; Superoxide Dismutase; Titrimetry | 2000 |
Amyotrophic lateral sclerosis: fasting plasma levels of cysteine and inorganic sulfate are normal, as are brain contents of cysteine.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Brain; Cysteine; Fasting; Humans; Middle Aged; Reference Values; Sulfates | 1991 |